La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Dexxos Participações Croissance future
Future contrôle des critères 1/6
Dexxos Participações devrait augmenter ses bénéfices et ses revenus de 5.4% et de 14.6% par an respectivement, tandis que le BPA devrait croître de croître de 6% par an.
Informations clés
5.4%
Taux de croissance des bénéfices
6.0%
Taux de croissance du BPA
Chemicals croissance des b énéfices | 50.9% |
Taux de croissance des recettes | 14.6% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 09 Aug 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Dexxos Participações' (BVMF:DEXP3) Solid Earnings Have Been Accounted For Conservatively
Apr 01Dexxos Participações (BVMF:DEXP3) Is Very Good At Capital Allocation
Nov 11Why We Like The Returns At Dexxos Participações (BVMF:DEXP3)
Mar 30Should You Investigate Dexxos Participações S.A. (BVMF:DEXP3) At R$8.07?
Jan 26Do Dexxos Participações' (BVMF:DEXP3) Earnings Warrant Your Attention?
Oct 26Is Dexxos Participações (BVMF:DEXP3) Using Too Much Debt?
Sep 06Under The Bonnet, Dexxos Participações' (BVMF:DEXP3) Returns Look Impressive
Aug 15At R$8.17, Is Dexxos Participações S.A. (BVMF:DEXP3) Worth Looking At Closely?
Jun 11We Think Dexxos Participa ções (BVMF:DEXP3) Can Stay On Top Of Its Debt
May 17Returns On Capital Are A Standout For Dexxos Participações (BVMF:DEXP3)
Apr 12Here's Why I Think Dexxos Participações (BVMF:DEXP3) Might Deserve Your Attention Today
Jan 26Dexxos Participações (BVMF:DEXP3) Knows How To Allocate Capital Effectively
Jan 05Dexxos Participações (BVMF:DEXP3) Has A Pretty Healthy Balance Sheet
Dec 07Here's Why I Think Dexxos Participações (BVMF:DEXP3) Is An Interesting Stock
Oct 22Dexxos Participações (BVMF:DEXP3) Seems To Use Debt Quite Sensibly
Sep 05Dexxos Participações (BVMF:DEXP3) Is Achieving High Returns On Its Capital
Aug 07If You Like EPS Growth Then Check Out GPC Participações (BVMF:DEXP3) Before It's Too Late
May 27We Think GPC Participações (BVMF:GPCP3) Can Stay On Top Of Its Debt
May 10The Attractive Combination That Could Earn GPC Participações S.A. (BVMF:GPCP3) A Place In Your Dividend Portfolio
Apr 02Are Strong Financial Prospects The Force That Is Driving The Momentum In GPC Participações S.A.'s BVMF:GPCP3) Stock?
Feb 26Do Institutions Own GPC Participações S.A. (BVMF:GPCP3) Shares?
Feb 05Does GPC Participações (BVMF:GPCP3) Have A Healthy Balance Sheet?
Jan 18GPC Participações (BVMF:GPCP3) Is Growing Earnings But Are They A Good Guide?
Jan 01Is There More Growth In Store For GPC Participações' (BVMF:GPCP3) Returns On Capital?
Dec 14Shareholders of GPC Participações (BVMF:GPCP3) Must Be Delighted With Their 884% Total Return
Nov 26Can You Imagine How Jubilant GPC Participações' (BVMF:GPCP3) Shareholders Feel About Its 297% Share Price Gain?
Aug 12Announcing: GPC Participações (BVMF:GPCP3) Stock Increased An Energizing 297% In The Last Three Years
Aug 12Investors Don't See Light At End Of GPC Participações S.A.'s (BVMF:GPCP3) Tunnel
Jul 13Has GPC Participações S.A.'s (BVMF:GPCP3) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Jul 02Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2025 | 2,123 | 177 | N/A | 207 | 1 |
12/31/2024 | 2,005 | 162 | N/A | 170 | 1 |
6/30/2024 | 1,660 | 165 | 177 | 246 | N/A |
3/31/2024 | 1,664 | 176 | 240 | 275 | N/A |
12/31/2023 | 1,745 | 181 | 315 | 340 | N/A |
9/30/2023 | 1,801 | 160 | 324 | 352 | N/A |
6/30/2023 | 1,840 | 148 | 313 | 345 | N/A |
3/31/2023 | 1,953 | 137 | 186 | 227 | N/A |
12/31/2022 | 2,098 | 150 | 159 | 202 | N/A |
9/30/2022 | 2,178 | 134 | 36 | 85 | N/A |
6/30/2022 | 2,182 | 173 | -17 | 38 | N/A |
3/31/2022 | 2,043 | 210 | -35 | 16 | N/A |
12/31/2021 | 1,774 | 192 | -100 | -48 | N/A |
9/30/2021 | 1,494 | 197 | -38 | 6 | N/A |
6/30/2021 | 1,328 | 151 | -47 | -16 | N/A |
3/31/2021 | 1,109 | 148 | 62 | 87 | N/A |
12/31/2020 | 995 | 119 | 93 | 116 | N/A |
9/30/2020 | 915 | 98 | 92 | 102 | N/A |
6/30/2020 | 842 | 88 | 87 | 109 | N/A |
3/31/2020 | 848 | 28 | -1 | 25 | N/A |
12/31/2019 | 798 | 25 | -22 | 1 | N/A |
9/30/2019 | 794 | 29 | -1 | 31 | N/A |
6/30/2019 | 769 | 23 | -24 | -2 | N/A |
3/31/2019 | 728 | 8 | -25 | -6 | N/A |
12/31/2018 | 735 | 7 | -6 | 11 | N/A |
9/30/2018 | 679 | 88 | -79 | -69 | N/A |
6/30/2018 | 613 | 89 | -46 | -38 | N/A |
3/31/2018 | 561 | 91 | N/A | -5 | N/A |
12/31/2017 | 484 | 81 | N/A | -9 | N/A |
9/30/2017 | 445 | 61 | N/A | 61 | N/A |
6/30/2017 | 433 | 41 | N/A | 48 | N/A |
3/31/2017 | 438 | 47 | N/A | 40 | N/A |
12/31/2016 | 438 | 53 | N/A | 39 | N/A |
9/30/2016 | 437 | -25 | N/A | 34 | N/A |
6/30/2016 | 428 | -28 | N/A | 39 | N/A |
3/31/2016 | 411 | -38 | N/A | 32 | N/A |
12/31/2015 | 398 | -41 | N/A | 36 | N/A |
9/30/2015 | 390 | -23 | N/A | 23 | N/A |
6/30/2015 | 376 | -15 | N/A | 17 | N/A |
3/31/2015 | 366 | -20 | N/A | 18 | N/A |
12/31/2014 | 367 | -20 | N/A | 4 | N/A |
9/30/2014 | 362 | 71 | N/A | 3 | N/A |
6/30/2014 | 365 | 55 | N/A | -6 | N/A |
3/31/2014 | 355 | 52 | N/A | 20 | N/A |
12/31/2013 | 349 | 32 | N/A | 33 | N/A |
9/30/2013 | 368 | -79 | N/A | 48 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de DEXP3 ( 5.4% par an) est inférieure au taux d'épargne ( 10.1% ).
Bénéfices vs marché: Les bénéfices de DEXP3 ( 5.4% par an) devraient croître plus lentement que le marché BR ( 14.4% par an).
Croissance élevée des bénéfices: Les bénéfices de DEXP3 devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de DEXP3 ( 14.6% par an) devrait croître plus rapidement que le marché BR ( 7.7% par an).
Croissance élevée des revenus: Le chiffre d'affaires de DEXP3 ( 14.6% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de DEXP3 devrait être élevé dans 3 ans